Trade

with

Myriad Genetics Inc
(NASDAQ: MYGN)
AdChoices
38.00
+0.40
+1.06%
After Hours :
38.00
0.00
0.00%

Open

37.91

Previous Close

37.60

Volume (Avg)

420.44k (770.09k)

Day's Range

37.78-38.49

52Wk Range

20.02-42.50

Market Cap.

2.77B

Dividend Rate ( Yield )

-

Beta

0.99

Shares Outstanding

72.37M

P/E Ratio (EPS)

16.86 (2.25)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Hold
    • Revenue

    • -

    • Net Income

    • -

    • Market Cap.

    • 2.77B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 22.64

    • PEG (Price/Earnings Growth) Ratio

    • 1.62

    • Beta

    • 0.99

    • Forward P/E

    • 20.04

    • Price/Sales

    • 3.82

    • Price/Book Value

    • 3.85

    • Price/Cash flow

    • 14.39

      • EBITDA

      • -

      • Return on Capital %

      • 21.65

      • Return on Equity %

      • 24.35

      • Return on Assets %

      • 21.65

      • Book Value/Share

      • 9.88

      • Shares Outstanding

      • 72.37M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 43.50

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • 2.19

        • Cashflow Estimate

        • 2.51

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.40

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • 19.80

          • -5.55

          • Net Income

            Q/Q (last year)

          • -23.70

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 18.97

          • 47.82

          • Net Income

            5-Year Annual Average

          • 5.30

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 85.97

            • 42.70

            • Pre-Tax Margin

            • 35.71

            • 11.63

            • Net Profit Margin

            • 22.64

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 87.20

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 37.90

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 27.30

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 4.00

              • 1.23

              • Quick Ratio

              • 3.37

              • 0.76

              • Interest Coverage

              • -

              • 5.98

              • Leverage Ratio

              • 1.15

              • 2.16

              • Book Value/Share

              • 9.88

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 15.53

                • 32.79

                • P/E Ratio 5-Year High

                • 18.86

                • 325.07

                • P/E Ratio 5-Year Low

                • 6.26

                • 154.73

                • Price/Sales Ratio

                • 3.52

                • 2.30

                • Price/Book Value

                • 3.54

                • 2.98

                • Price/Cash Flow Ratio

                • 14.39

                • 18.76

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 24.35

                        (22.60)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • 21.65

                        (20.80)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 24.35

                        (22.60)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • 106.87k

                      • 17.17k

                      • Inventory Turnover

                      • 7.55

                      • 5.07

                      • Asset Turnover

                      • 0.96

                      • 0.48

                      Current Historical
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      72.60%

                      Mutual Fund Ownership

                      70.72%

                      Float

                      62.30%

                      5% / Insider Ownership

                      1.72%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Royce Premier Fund

                      •  

                        5,969,565

                      • -5.90

                      • 8.20

                      • VA CollegeAmerica Small Cap World

                      •  

                        5,725,556

                      • 2.05

                      • 7.87

                      • VA CollegeAmerica New Economy

                      •  

                        2,962,495

                      • 1.36

                      • 4.07

                      • American Funds NVIT Growth

                      •  

                        2,735,000

                      • 80.04

                      • 3.76

                      • Undrly Baillie Giff Global Alpha Pen

                      •  

                        1,553,494

                      • 0.00

                      • 2.11

                      • First Trust NYSE Arca Biotech Fund

                      •  

                        1,468,685

                      • 0.00

                      • 1.97

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        1,427,043

                      • 0.00

                      • 1.96

                      • Manulife Canadian Focused Fund

                      •  

                        1,312,281

                      • -0.36

                      • 1.79

                      • American Funds IS® Gbl Sm Cap

                      •  

                        1,274,898

                      • 5.11

                      • 1.75

                      • Vanguard Small Cap Index

                      •  

                        1,264,435

                      • -3.03

                      • 1.74

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Royce & Associates, LLC

                      •  

                        9,299,478

                      • -1.44%

                      • 12.65

                      • Baillie Gifford & Co Limited.

                      •  

                        8,785,503

                      • +1.37%

                      • 11.95

                      • Capital Research Global Investors

                      •  

                        8,717,609

                      • +3.42%

                      • 11.86

                      • BB&T SECURITIES, LLC

                      •  

                        5,865,460

                      • +905.22%

                      • 8.06

                      • Capital World Investors

                      •  

                        5,295,079

                      • +65.73%

                      • 7.20

                      • Vanguard Group, Inc.

                      •  

                        5,050,663

                      • +3.70%

                      • 6.87

                      • Scopia Management Inc.

                      •  

                        2,851,267

                      • +22.37%

                      • 3.88

                      • First Trust Advisors L.P.

                      •  

                        2,846,052

                      • +22.31%

                      • 3.87

                      • Iridian Asset Management LLC

                      •  

                        2,696,216

                      • +5.00%

                      • 3.67

                      • Tiger Technology Management LLC

                      •  

                        1,900,000

                      • -19.01%

                      • 2.59

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Aggressive Growth

                      Style

                      Small Growth

                      Myriad Genetics Inc is a molecular diagnostic company, engaged in making a difference in patients lives through the discovery and commercialization of transformative tests which assess a persons risk of developing disease, guide trea...moretment decisions and assess risk of disease progression and recurrence. The Companys business segments include: research, molecular diagnostics and companion diagnostics. The research segment is engaged in the discovery of genes related to major common diseases and includes corporate services such as finance, human resources, legal, and information technology. The molecular diagnostics segment provides testing that is designed to assess an individuals risk for developing disease later in life, identify a patients likelihood of responding to drug therapy and guide a patien...morets dosing to ensure optimal treatment, or assess a patients risk of disease progression and disease recurrence. The companion diagnostics segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries. The Company offers nine commercial molecular diagnostic tests, including six predictive medicine tests, two personalized medicine tests, and one prognostic medicine test. The Company markets these tests through its sales force of approximately 400 people in the United States. It also markets BRACAnalysis, COLARIS, COLARIS AP, and Prolaris tests through its European sales force. The Companys competitors include other molecular diagnostic companies, diagnostic reference laboratories, large multi-national healthcare companies, and universities and other research institutions. The Company has 234 patents as well as patent applications in the United States and foreign countries. The patents and patent applications cover diagnostic biomarkers, genes, proteins, gene expression signatures, antibodies, primers, probes, assays, disease-associated genetic mutations and single-nucleotide polymorphisms, methods for determining genetic predisposition, methods for disease diagnosis, methods for determining disease progression, methods for correlation claims, and methods for disease treatment, and general molecular diagnostic techniques. The Companys U.S. patents relating to BRACAnalysis, COLARIS, COLARIS AP, MELARIS, PREZEON, PANEXIA and TruCulture also have related foreign issued patents in countries, including in Europe, Canada, Japan, Australia and New Zealand, claiming similar subject matter and having similar expiration dates. The services that the Company provides are regulated by federal, state and foreign governmental authorities.lessless

                      Key People

                      Mr. Peter D. Meldrum

                      CEO/Director/President

                      Dr. John T. Henderson, M.D.

                      Chairman of the Board/Director

                      Dr. Walter Gilbert,PhD

                      Director/Vice Chairman of the Board

                      Mr. R. Bryan Riggsbee

                      Executive VP/CFO/Treasurer

                      Mr. Robert G. Harrison

                      Chief Information Officer

                      • Myriad Genetics Inc

                      • 320 Wakara Way

                      • Salt Lake City, UT 84108

                      • USA.Map

                      • Phone: +1 801 584-3600

                      • Fax: +1 801 584-3640

                      • myriad.com

                      Incorporated

                      1991

                      Employees

                      1,649

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: